MedTrace Logo

Genetics of Arteriovenous Malformations

NCT02445430 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2021-09-21

No results posted yet for this study

Summary

The goal of this study is to identify genetic alterations resulting in the development of arteriovenous malformation (AVM) in the central nervous system.

Conditions

  • Arteriovenous Malformation

Sponsors & Collaborators

  • Translational Genomics Research Institute

    collaborator OTHER

  • The Joe Niekro Foundation

    collaborator UNKNOWN

  • St. Joseph's Hospital and Medical Center, Phoenix

    lead OTHER

Principal Investigators

  • Joseph Zabramski, MD · Barrow Neurosurgical Associates

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2022-06-30
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02445430 on ClinicalTrials.gov